Page last updated: 2024-11-05

thiotepa and Genetic Diseases

thiotepa has been researched along with Genetic Diseases in 3 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosales, F1
Peylan-Ramu, N1
Cividalli, G1
Varadi, G1
Or, R1
Naparstek, E1
Slavin, S1
Nagler, A1
Galotto, M1
Berisso, G1
Delfino, L1
Podesta, M1
Ottaggio, L1
Dallorso, S1
Dufour, C1
Ferrara, GB1
Abbondandolo, A1
Dini, G1
Bacigalupo, A1
Cancedda, R1
Quarto, R1
Bochkov, NP1

Other Studies

3 other studies available for thiotepa and Genetic Diseases

ArticleYear
The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
    Bone marrow transplantation, 1999, Volume: 23, Issue:9

    Topics: Adolescent; Alkylating Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclo

1999
Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients.
    Experimental hematology, 1999, Volume: 27, Issue:9

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone M

1999
[Mutation process in man].
    Vestnik Akademii meditsinskikh nauk SSSR, 1976, Issue:7

    Topics: Chromosome Aberrations; Chromosomes; Genetic Diseases, Inborn; Humans; Mutagens; Mutation; Thiotepa

1976